amlantiantibodiesassociatedbonebortezomibbrentuximabcancercarechemotherapycombinationcommondaratumumabdeliverydevelopmentdexamethasonediagnoseddifferdifferentdosedosingemergingenasidenibfuhighhodgkinidh2infusionixazomiblenalidomideleukemialymphomamaintenancemanagemanagementmdsmmmultiplemutantmyelomanewlyolderoptimalpancreaticpatientpatientspdprofilereactionreceivingregimenrenalrisksafetyseverestandardstatusstrategystudytakingtherapytransplanttreatedvedotin